Hinge Health (NYSE:HNGE) Stock Breaks Below Fifty Day Moving Average - What's Next?

Hinge Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Hinge Health shares fell below their 50-day moving average of $106.02, trading as low as $103.12 and last at $105.65.
  • Analysts remain broadly positive: the consensus rating is “Buy,” with an average price target of $118.93; several firms recently raised their targets.
  • The company reported quarterly EPS of $0.71, beating the $0.27 consensus, while revenue rose 52.4% year over year to $234.97 million.
  • Five stocks we like better than Hinge Health.

Hinge Health Inc. (NYSE:HNGE - Get Free Report)'s share price passed below its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $106.02 and traded as low as $103.12. Hinge Health shares last traded at $105.65, with a volume of 1,649,319 shares.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the stock. Stifel Nicolaus boosted their target price on shares of Hinge Health from $130.00 to $135.00 and gave the stock a "buy" rating in a research report on Tuesday, November 3rd. Citizens Jmp boosted their price objective on Hinge Health from $96.00 to $107.00 and gave the stock a "market outperform" rating in a research note on Wednesday, August 5th. Truist Financial lifted their price target on shares of Hinge Health from $112.00 to $145.00 and gave the stock a "buy" rating in a research report on Tuesday, November 3rd. Evercore reissued an "outperform" rating and issued a $105.00 target price on shares of Hinge Health in a research report on Wednesday, August 5th. Finally, KeyCorp increased their price objective on Hinge Health from $125.00 to $140.00 and gave the stock an "overweight" rating in a research note on Friday, October 16th. Two analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $118.93.

Read Our Latest Report on HNGE

Hinge Health Stock Down 2.3%

The firm has a market capitalization of $8.59 billion, a P/E ratio of 53.90, a PEG ratio of 1.71 and a beta of 1.19. The business has a 50-day moving average price of $106.02 and a 200-day moving average price of $72.75.

Hinge Health (NYSE:HNGE - Get Free Report) last issued its quarterly earnings data on Monday, November 2nd. The company reported $0.71 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.27 by $0.44. Hinge Health had a return on equity of 66.96% and a net margin of 21.02%. The company had revenue of $234.97 million during the quarter. During the same period in the previous year, the business posted ($0.02) earnings per share. The firm's revenue was up 52.4% compared to the same quarter last year. As a group, sell-side analysts forecast that Hinge Health Inc. will post 1.56 EPS for the current year.

Insiders Place Their Bets

In other Hinge Health news, CFO James Budge sold 55,561 shares of the business's stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $89.45, for a total value of $4,969,931.45. Following the completion of the transaction, the chief financial officer directly owned 349,062 shares of the company's stock, valued at approximately $31,223,595.90. The trade was a 13.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President James Pursley sold 33,000 shares of the company's stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of $94.14, for a total value of $3,106,620.00. Following the transaction, the president directly owned 666,909 shares of the company's stock, valued at approximately $62,782,813.26. This trade represents a 4.71% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 1,226,288 shares of company stock valued at $121,470,244. Insiders own 18.92% of the company's stock.

Institutional Trading of Hinge Health

Several hedge funds and other institutional investors have recently bought and sold shares of the business. American Century Companies Inc. grew its position in Hinge Health by 111.2% in the third quarter. American Century Companies Inc. now owns 260,853 shares of the company's stock valued at $25,365,000 after acquiring an additional 137,352 shares during the last quarter. Kestra Advisory Services LLC bought a new stake in shares of Hinge Health during the 3rd quarter valued at approximately $242,000. Liontrust Investment Partners LLP acquired a new stake in Hinge Health in the third quarter valued at approximately $4,123,000. Zacks Investment Management acquired a new position in Hinge Health in the 3rd quarter worth about $4,075,000. Finally, Regal Partners Ltd acquired a new stake in shares of Hinge Health during the third quarter valued at about $1,050,000.

Hinge Health Company Profile

(Get Free Report)

Hinge Health is a digital health company focused on musculoskeletal care, including support for people with back, joint and muscle pain. Its services are designed to help members manage conditions through personalized, technology-enabled care. The company's offerings include app-based exercise therapy, education and behavioral support, along with access to clinical care teams. Hinge Health also uses wearable motion sensors in some programs to guide and track exercises. Founded in 2015, Hinge Health primarily provides its services through employers and health plans.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Hinge Health Right Now?

Before you consider Hinge Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.

While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines